-
-
-
-
-
-
-
Eton Pharmaceuticals Announces CFO Succession Plan
-
-
-
-
-
-
-
Eton Pharmaceuticals (ETON) Out-Licenses International Rights to Increlex
-
-
-
-
-
-
-
Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of GalzinĀ®
-
-
-
-
-
-
-
Eton Pharmaceuticals (ETON) PT Raised to $15 at Craig-Hallum
-
-
-
-
-
-
-
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKEĀ® for Phenylketonuria
-
-
-
-
-
-
-
Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results
-
-
-
-
-
-
-
Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results
-
1,180,395 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

